👁️8,956
GitHubLinkedIn
AI Organizations and Media4 min read638 words

💰 YouTube - Faceless Channel Monetization

👁️0reads (human + AI)🤖0AI ingestions

💰 YouTube - Faceless Channel Monetization

This article explores the potential earnings of a faceless YouTube channel based on viewership and provides a link to further information.

Key Points:

• 1k views: $5.35

• 10k views: $53.50

• 100k views: $535

• 1m views: $5,350

• 10m views: $53,000

🔗 Resources:

Mega.apob.ai ↗ - Monetization guide

Image

Image


💡 Immigration - Open Borders and Entitlement

This article discusses the perceived sense of entitlement surrounding immigration policies and the consequences of open border experiments.

Key Points:

• Criticism of entitled attitudes towards immigration.

• Discussion on the unintended consequences of open borders.

🔗 Resources:

Ayomidejoe's Tweet ↗ - Analysis of immigration policies


✨ AI - GPT-4.5 Capabilities

This article highlights the expressive and creative capabilities of GPT-4.5 and suggests that better naming might increase its adoption.

Key Points:

• GPT-4.5 excels in generating emotionally nuanced and creative responses.

• Ideal for "what if" scenarios and understanding diverse perspectives.

• Differentiation from previous GPT models is not readily apparent.

🔗 Resources:

Slow Developer's Tweet ↗ - Discussion of GPT-4.5 features


🚀 Business - Coinbase's Founding Story

This article summarizes Brian Armstrong's reflection on starting Coinbase, focusing on overcoming self-doubt and addressing significant world issues.

Key Points:

• Overcoming self-doubt in entrepreneurship.

• Identifying and tackling significant global challenges.

🔗 Resources:

Overlap Tech's Tweet ↗ - Brian Armstrong's reflections

Image

Image


🤖 AI - Qwen3 Quantized Models Release

This article announces the release of quantized models for Qwen3, detailing their availability through various platforms and formats.

Key Points:

• Qwen3 is now available in quantized formats.

• Multiple deployment options including Ollama, LM Studio, SGLang, and vLLM.

• Support for GGUF, AWQ, and GPTQ formats.

🔗 Resources:

Alibaba Qwen's Tweet ↗ - Announcement of Qwen3 release

Image

Image


💡 Google Ads - Improving Conversion Rates

This article identifies the primary cause of low search ad conversion rates and introduces an AI solution to address it.

Key Points:

• Static landing pages are the main reason for low conversion rates.

• An AI agent is developed to fix this issue.

🔗 Resources:

Pritam Roy's Tweet ↗ - Analysis and solution for low conversion rates

Image

Image


✨ AI - Prompt Engineering Example

This article showcases a prompt for generating images of objects carved from soap, emphasizing texture and detail.

Key Points:

• Detailed prompt for generating soap carving images.

🔗 Resources:

icreatelife's Tweet ↗ - Prompt engineering example

Image

Image


Image

Image


Image

Image


Image

Image


🤖 SEO - Influencing LLMs for SEO

This article explores the use of LLMs for content creation and SEO, including strategies for influencing LLM outputs for specific subjects.

Key Points:

• LLMs can be used for website and social media content creation.

• Strategies exist to influence LLM output for specific subjects.

🔗 Resources:

AiJohnAllen's Tweet ↗ - Discussion on influencing LLMs for SEO


🚀 Automotive - China's Car Trade-in Subsidy Program

This article reports on the high number of applications for China's nationwide car trade-in subsidy program.

Key Points:

• Over 10 million applications received for the car trade-in subsidy program.

• 3.225 million applications submitted in 2025 alone.

🔗 Resources:

rwang07's Tweet ↗ - Report on China's car trade-in subsidy program

Image

Image


💡 Pharmaceuticals - Clinical Trial Concerns

This article discusses concerns surrounding a pharmaceutical clinical trial, focusing on allegations of unblinded cohorts and implications for all-cause mortality.

Key Points:

• Concerns about a pharmaceutical clinical trial.

• Allegations of unblinded cohorts during the study.

🔗 Resources:

DowdEdward's Tweet ↗ - Discussion on pharmaceutical clinical trial concerns

Image

Image


⭐️ Support

If you liked reading this report, please star ⭐️ this repository and follow me on Github ↗, 𝕏 (previously known as Twitter) ↗ to help others discover these resources and regular updates.


Related AI Organizations and Media Breakdowns

Drix10
Written by Drix10

Co founder @ PartPilot | 1 x Acquired Founder | Canopy @ f.inc | Cybersec @ DSU | 2x International Hackathon 🏆. Read more on drix10.com.